I n this Journal, we have recently highlighted the progress of the Canadian Association of Gastroenterology (CAG) in meeting the goals and objectives outlined in the first Strategic Plan developed in 1993 (1) . In September 2002, a Strategic Planning survey was mailed to all members of the CAG (a copy of the cover letter and survey are present for viewing on the CAG Web site <www.cag-acg.org/whatsnew/strat_plann_surv.htm>). The results of the responses to this survey were collated and presented to the Past Presidents of the CAG at a retreat held during the summer of 2003. These findings were then employed to develop a Strategic Plan for the CAG to guide its progress and development over the next five to ten years. A subsequent issue of this Journal will include a presentation of the CAG 2004 Strategic Plan, which was finalized and approved by the CAG Governing Board during the annual fall meeting in October 2003.
The Strategic Planning survey was returned to the National Office by 188 members of the CAG. A set of slides that provides a detailed summary of the entire survey is presented on the CAG Web site. A more abbreviated synopsis is provided here for your consideration. The CAG is proud to acknowledge its Benefactor Corporate Sponsors: Abbott Laboratories Ltd.
AstraZeneca Canada Inc. Axcan Pharma Inc. Janssen-Ortho Inc. Pfizer Canada Inc. Figure 3 ) The findings in this figure reflect current (open bars) and desired (solid bars) influence when members were asked "how strong a role does or should the CAG exert in the following areas?" The scale used in the survey ranked from -5 (not strong at all) to +5 (very strong). CAG Canadian Association of Gastroenterology related to issues of advocacy, lobbying, and our relationships with other societies and organizations.
Mean Score
As shown in Figure 4 , there is strong support for the CAG to become more involved in issues of advocacy with a variety of partners, including provincial and federal governments, national funding agencies and national medical specialty societies. Figure 5 indicates the areas ranked by members of the CAG as high priority items warranting CAG time, energy and resources in the future. These issues formed the basis of the discussions undertaken to develop a new CAG Strategic Plan, which will be presented to you in these pages in the near future.
We very much welcome comments and feedback regarding the results and analysis of the 2002 Strategic Planning survey, which can be forwarded to the CAG National Office at CAGOffice@cag-acg.org. The CAG leadership values your input and insights. The future development of the organization relies upon the collective enthusiasm and support of all members of the CAG from across the nation.
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